Bull
$100.19
Scenario price
$64.000
+0.198 (+0.31%)At close
DocuSign, Inc. provides intelligent agreement management (IAM) platform an eSignature solution, and contract lifecycle management (CLM) solution - allow organizations to increase productivity, accelerate contract review cycles, and transform agreement data into insights and actions. The Company’s IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (AI) capabilities, enabling organizations to create, commit, and manage agreements virtually. Its products include eSignature, CLM, IAM Apps, and Add-on Products. Its Add-on Products include Payments to collect payments along with signed agreements; Identity and standards-based signature for enhanced signer-identification and signatures with digital certification; Notary for remote online notarization; Monitor for advanced analytics; Gen for Salesforce for automated agreement generation within Salesforce, among others.
DocuSign is a good buy right now due to its current price of $64, which is below the analyst price target of $60 from BTIG, indicating potential upside. Additionally, the forward P/E ratio of 13.986 suggests that the stock is reasonably valued relative to its expected earnings growth. The main risk is the insider selling, which has increased by 161.71% over the last month, indicating potential concerns among insiders.
BofA
$58
2026-08-28
BofA
2026-08-28
Price Target
$58
Wedbush
$58
2026-06-05
Wedbush
2026-06-05
Price Target
$58
BTIG
$60
2026-06-05
BTIG
2026-06-05
Price Target
$60
Wells Fargo
$55
2026-06-05
Wells Fargo
2026-06-05
Price Target
$55
Citi
$54
2026-06-05
Citi
2026-06-05
Price Target
$54
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

This Week's Focus: Broadcom and Palo Alto Earnings

Salesforce Q2 Results Exceed Expectations, Stock Soars

Thomson Reuters and DocuSign Shares Drop Amid AI Disruption Fears

Docusign Market Trends and Investment Opportunities Analysis

Docusign to Release Q2 FY2027 Financial Results
DocuSign, Inc. provides intelligent agreement management (IAM) platform an eSignature solution, and contract lifecycle management (CLM) solution - allow organizations to increase productivity, accelerate contract review cycles, and transform agreement data into insights and actions. The Company’s IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (AI) capabilities, enabling organizations to create, commit, and manage agreements virtually. Its products include eSignature, CLM, IAM Apps, and Add-on Products. Its Add-on Products include Payments to collect payments along with signed agreements; Identity and standards-based signature for enhanced signer-identification and signatures with digital certification; Notary for remote online notarization; Monitor for advanced analytics; Gen for Salesforce for automated agreement generation within Salesforce, among others. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
DocuSign is a good buy right now due to its current price of $64, which is below the analyst price target of $60 from BTIG, indicating potential upside. Additionally, the forward P/E ratio of 13.986 suggests that the stock is reasonably valued relative to its expected earnings growth. The main risk is the insider selling, which has increased by 161.71% over the last month, indicating potential concerns among insiders.
8 analysts cover DOCU: 5 rate it Buy, 3 Hold and 0 Sell. The average price target is 80.23.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.